-
1
-
-
84978619576
-
-
Luxembourg: Publications Office of the European Union
-
European Statistical System. The ESS Report 2014. Luxembourg: Publications Office of the European Union, 2015.
-
(2015)
The ESS Report 2014
-
-
-
2
-
-
84896393337
-
Vaccine-preventable diseases: from paediatric to adult targets
-
24389370
-
S.Esposito, P.Durando, S.Bosis, F.Ansaldi, C.Tagliabue, G.Icardi, ESCMID Vaccine Study Group (EVASG). Vaccine-preventable diseases: from paediatric to adult targets. Eur J Intern Med 2014; 25: 203-212; PMID:24389370; http://dx.doi.org/10.1016/j.ejim.2013.12.004
-
(2014)
Eur J Intern Med
, vol.25
, pp. 203-212
-
-
Esposito, S.1
Durando, P.2
Bosis, S.3
Ansaldi, F.4
Tagliabue, C.5
Icardi, G.6
-
3
-
-
77649278648
-
Vaccination and healthy aging
-
20192710
-
S.Maggi. Vaccination and healthy aging. Expert Rev Vaccines 2010; 9 (3 Suppl.):3-6; PMID:20192710; http://dx.doi.org/10.1586/erv.10.26
-
(2010)
Expert Rev Vaccines
, vol.9
, Issue.3
, pp. 3-6
-
-
Maggi, S.1
-
4
-
-
84863426446
-
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
-
22579043
-
K.Barnett, S.W.Mercer, M.Norbury, G.Watt, S.Wyke, B.Guthrie. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380:37-43; PMID:22579043; http://dx.doi.org/10.1016/S0140-6736(12)60240-2
-
(2012)
Lancet
, vol.380
, pp. 37-43
-
-
Barnett, K.1
Mercer, S.W.2
Norbury, M.3
Watt, G.4
Wyke, S.5
Guthrie, B.6
-
6
-
-
84957839649
-
Burden of four vaccine preventable diseases in older adults
-
Epub Jan 3, 2675206
-
M.Kristensen, A.van Lier, R.Eilers, S.A.McDonald, W.Opstelten, N.van der Maas, W.van der Hoek, M.E.Kretzschmar, M.M.Nielen, H.E.de Melker. Burden of four vaccine preventable diseases in older adults. Vaccine 2016; 34:942-9; Epub Jan 3; PMID:2675206
-
(2016)
Vaccine
, vol.34
, pp. 942-949
-
-
Kristensen, M.1
van Lier, A.2
Eilers, R.3
McDonald, S.A.4
Opstelten, W.5
van der Maas, N.6
van der Hoek, W.7
Kretzschmar, M.E.8
Nielen, M.M.9
de Melker, H.E.10
-
7
-
-
29244469121
-
European Respiratory Society, European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections
-
16319346
-
M.Woodhead, F.Blasi, S.Ewig, G.Huchon, M.Ieven, A.Ortqvist, T.Schaberg, A.Torres, G.van der Heijden, T.J.Verheij. European Respiratory Society, European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26:1138-80; PMID:16319346; http://dx.doi.org/10.1183/09031936.05.00055705
-
(2005)
Eur Respir J
, vol.26
, pp. 1138-1180
-
-
Woodhead, M.1
Blasi, F.2
Ewig, S.3
Huchon, G.4
Ieven, M.5
Ortqvist, A.6
Schaberg, T.7
Torres, A.8
van der Heijden, G.9
Verheij, T.J.10
-
8
-
-
85011025632
-
Vaccines for preventing influenza in healthy adults
-
24623315
-
T.Jefferson, C.Di Pietrantonj, A.Rivetti, G.A.Bawazeer, L.A.Al-Ansary, E.Ferroni. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014; 3:CD001269; PMID:24623315
-
(2014)
Cochrane Database Syst Rev
, vol.3
, pp. CD001269
-
-
Jefferson, T.1
Di Pietrantonj, C.2
Rivetti, A.3
Bawazeer, G.A.4
Al-Ansary, L.A.5
Ferroni, E.6
-
9
-
-
84856587177
-
Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008–2010: results from a cohort study in general practice
-
22178524
-
P.Hardelid, D.M.Fleming, N.Andrews, M.Barley, H.Durnall, P.Mangtani, R.Pebody. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008–2010: results from a cohort study in general practice. Vaccine 2012; 30:1371-8; PMID:22178524; http://dx.doi.org/10.1016/j.vaccine.2011.12.038
-
(2012)
Vaccine
, vol.30
, pp. 1371-1378
-
-
Hardelid, P.1
Fleming, D.M.2
Andrews, N.3
Barley, M.4
Durnall, H.5
Mangtani, P.6
Pebody, R.7
-
10
-
-
84887151361
-
Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study
-
24103037
-
G.Kafatos, R.Pebody, N.Andrews, H.Durnall, M.Barley, D.Fleming. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study. Influenza Other Respir Viruses 2013; 7:1175-80; PMID:24103037; http://dx.doi.org/10.1111/irv.12163
-
(2013)
Influenza Other Respir Viruses
, vol.7
, pp. 1175-1180
-
-
Kafatos, G.1
Pebody, R.2
Andrews, N.3
Durnall, H.4
Barley, M.5
Fleming, D.6
-
11
-
-
84898047827
-
Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season
-
24497128
-
A.T.Kawai, L.Li, M.Kulldorff, C.Vellozzi, E.Weintraub, R.Baxter, E.A.Belongia, M.F.Daley, S.J.Jacobsen, A.Naleway, J.D.Nordin, G.M.Lee. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season. Pharmacoepidemiol Drug Saf 2014; 23:548-53; PMID:24497128; http://dx.doi.org/10.1002/pds.3575
-
(2014)
Pharmacoepidemiol Drug Saf
, vol.23
, pp. 548-553
-
-
Kawai, A.T.1
Li, L.2
Kulldorff, M.3
Vellozzi, C.4
Weintraub, E.5
Baxter, R.6
Belongia, E.A.7
Daley, M.F.8
Jacobsen, S.J.9
Naleway, A.10
Nordin, J.D.11
Lee, G.M.12
-
12
-
-
70349962885
-
Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy
-
19840665
-
K.L.Nichol. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine 2009; 27:6305-11; PMID:19840665; http://dx.doi.org/10.1016/j.vaccine.2009.07.006
-
(2009)
Vaccine
, vol.27
, pp. 6305-6311
-
-
Nichol, K.L.1
-
13
-
-
84355162726
-
Network for Influenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010–2011: cohort and case-control study
-
22100636
-
J.Castilla, V.Martínez-Artola, E.Salcedo, I.Martínez-Baz, M.G.Cenoz, M.Guevara, N.Alvarez, F.Irisarri, J.Morán, A.Barricarte. Network for Influenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010–2011: cohort and case-control study. Vaccine 2012; 30:195-200; PMID:22100636; http://dx.doi.org/10.1016/j.vaccine.2011.11.024
-
(2012)
Vaccine
, vol.30
, pp. 195-200
-
-
Castilla, J.1
Martínez-Artola, V.2
Salcedo, E.3
Martínez-Baz, I.4
Cenoz, M.G.5
Guevara, M.6
Alvarez, N.7
Irisarri, F.8
Morán, J.9
Barricarte, A.10
-
14
-
-
79955406980
-
Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden
-
21507917
-
A.Ortqvist, I.Berggren, M.Insulander, B.de Jong, B.Svenungsson.Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis 2011; 52:1203-11; PMID:21507917; http://dx.doi.org/10.1093/cid/cir182
-
(2011)
Clin Infect Dis
, vol.52
, pp. 1203-1211
-
-
Ortqvist, A.1
Berggren, I.2
Insulander, M.3
de Jong, B.4
Svenungsson, B.5
-
15
-
-
77957750627
-
Effect of influenza vaccination on hospitalizations in persons aged 50 years and older
-
20832494
-
R.Baxter, G.T.Ray, B.H.Fireman. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010; 28:7267-72; PMID:20832494; http://dx.doi.org/10.1016/j.vaccine.2010.08.088
-
(2010)
Vaccine
, vol.28
, pp. 7267-7272
-
-
Baxter, R.1
Ray, G.T.2
Fireman, B.H.3
-
16
-
-
84918505895
-
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons
-
25270645
-
H.Q.McLean, M.G.Thompson, M.E.Sundaram, J.K.Meece, D.L.McClure, T.C.Friedrich, E.A.Belongia. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 2014; 59:1375-85; PMID:25270645; http://dx.doi.org/10.1093/cid/ciu680
-
(2014)
Clin Infect Dis
, vol.59
, pp. 1375-1385
-
-
McLean, H.Q.1
Thompson, M.G.2
Sundaram, M.E.3
Meece, J.K.4
McClure, D.L.5
Friedrich, T.C.6
Belongia, E.A.7
-
17
-
-
84890861043
-
Hospital-based influenza morbidity and mortality surveillance system for influenza-like illnesses: a comparison with national influenza surveillance systems
-
24020512
-
Y.B.Seo, J.Y.Song, H.J.Cheong, Y.D.Cho, S.H.Wie, H.W.Jeong, W.J.Kim. Hospital-based influenza morbidity and mortality surveillance system for influenza-like illnesses: a comparison with national influenza surveillance systems. Influenza Other Respir Viruses 2014; 8:17-20; PMID:24020512; http://dx.doi.org/10.1111/irv.12175
-
(2014)
Influenza Other Respir Viruses
, vol.8
, pp. 17-20
-
-
Seo, Y.B.1
Song, J.Y.2
Cheong, H.J.3
Cho, Y.D.4
Wie, S.H.5
Jeong, H.W.6
Kim, W.J.7
-
18
-
-
84907407740
-
Contemporary vaccine challenges: improving global health one shot at a time
-
25210061
-
W.A.Orenstein, K.Seib, D.Graham-Rowe, S.Berkley. Contemporary vaccine challenges: improving global health one shot at a time. Sci Transl Med 2014; 6:253ps11; PMID:25210061; http://dx.doi.org/10.1126/scitranslmed.3009848
-
(2014)
Sci Transl Med
, vol.6
, pp. 253ps11
-
-
Orenstein, W.A.1
Seib, K.2
Graham-Rowe, D.3
Berkley, S.4
-
19
-
-
58749114378
-
Immunosenescence and vaccination in nursing home residents
-
T.Fulop, G.Pawelec, S.Castle, M.Loeb. Immunosenescence and vaccination in nursing home residents. Clin Infect Dis 2009; 48: 443-8; PMID:19140756; http://dx.doi.org/10.1086/596475
-
(2009)
Clin Infect Dis
, vol.48
, pp. 443-448
-
-
Fulop, T.1
Pawelec, G.2
Castle, S.3
Loeb, M.4
-
20
-
-
84983377006
-
Vaccinations in prisons: A shot in the arm for community health
-
26158401
-
V.G.Sequera, S.Valencia, A.L.García-Basteiro, A.Marco, J.M.Bayas. Vaccinations in prisons: A shot in the arm for community health. Hum Vaccin Immunother 2015; 11:2615-26; PMID:26158401; http://dx.doi.org/10.1080/21645515.2015.1051269
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 2615-2626
-
-
Sequera, V.G.1
Valencia, S.2
García-Basteiro, A.L.3
Marco, A.4
Bayas, J.M.5
-
22
-
-
3843053580
-
The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials
-
15297076
-
S.Conaty, L.Watson, J.Dinnes, N.Waugh. The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials. Vaccine 2004; 22:3214-24; PMID:15297076; http://dx.doi.org/10.1016/j.vaccine.2003.08.050
-
(2004)
Vaccine
, vol.22
, pp. 3214-3224
-
-
Conaty, S.1
Watson, L.2
Dinnes, J.3
Waugh, N.4
-
23
-
-
54049134138
-
23-valent pneumococcal polysaccharide vaccine. WHO position paper
-
18927997
-
World Health Organization. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec 2008; 83:373-384; PMID:18927997
-
(2008)
Wkly Epidemiol Rec
, vol.83
, pp. 373-384
-
-
-
24
-
-
84864772271
-
Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study
-
22789510
-
R.C.Hechter, C.Chao, S.J.Jacobsen, J.M.Slezak, V.P.Quinn, S.K.Van Den Eeden, H.F.Tseng. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine 2012; 30:5625-30; PMID:22789510; http://dx.doi.org/10.1016/j.vaccine.2012.06.085
-
(2012)
Vaccine
, vol.30
, pp. 5625-5630
-
-
Hechter, R.C.1
Chao, C.2
Jacobsen, S.J.3
Slezak, J.M.4
Quinn, V.P.5
Van Den Eeden, S.K.6
Tseng, H.F.7
-
25
-
-
33846874573
-
Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults
-
17254673
-
R.J.Singleton, J.C.Butler, L.R.Bulkow, D.Hurlburt, K.L.O'Brien, W.Doan, A.J.Parkinson, T.W.Hennessy. Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults. Vaccine 2007; 25:2288-95; PMID:17254673; http://dx.doi.org/10.1016/j.vaccine.2006.11.065
-
(2007)
Vaccine
, vol.25
, pp. 2288-2295
-
-
Singleton, R.J.1
Butler, J.C.2
Bulkow, L.R.3
Hurlburt, D.4
O'Brien, K.L.5
Doan, W.6
Parkinson, A.J.7
Hennessy, T.W.8
-
26
-
-
84941803502
-
The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease
-
Epub Aug 10, 26289973
-
N.Principi, S.Esposito. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease. Expert Rev Vaccines 2015; 14:1359-66; Epub Aug 10; PMID:26289973
-
(2015)
Expert Rev Vaccines
, vol.14
, pp. 1359-1366
-
-
Principi, N.1
Esposito, S.2
-
27
-
-
84925071077
-
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults
-
25785969
-
M.J.Bonten, S.M.Huijts, M.Bolkenbaas, C.Webber, S.Patterson, S.Gault, C.H.van Werkhoven, A.M.van Deursen, E.A.Sanders, T.J.Verheij, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 372: 1114-25; PMID:25785969; http://dx.doi.org/10.1056/NEJMoa1408544
-
(2015)
N Engl J Med
, vol.372
, pp. 1114-1125
-
-
Bonten, M.J.1
Huijts, S.M.2
Bolkenbaas, M.3
Webber, C.4
Patterson, S.5
Gault, S.6
van Werkhoven, C.H.7
van Deursen, A.M.8
Sanders, E.A.9
Verheij, T.J.10
-
28
-
-
84932092971
-
Update on emerging infections: news from the Centers for Disease Control and Prevention. Pertussis Epidemic—California, 2014
-
26097924
-
Centers for Disease Control and Prevention. Update on emerging infections: news from the Centers for Disease Control and Prevention. Pertussis Epidemic—California, 2014. Ann Emerg Med 2015; 65:568-70; PMID:26097924; http://dx.doi.org/10.1016/j.annemergmed.2015.02.009
-
(2015)
Ann Emerg Med
, vol.65
, pp. 568-570
-
-
-
29
-
-
84936990603
-
A survey of French general practitioners on the epidemiology of wounds in family practice
-
26124675
-
M.Sarazin, F.Roberton, R.Charles, A.Falchi, S.G.Chiappe, T.Blanchon, F.Lucht, T.Hanslik. A survey of French general practitioners on the epidemiology of wounds in family practice. Int J Gen Med 2015; 8:215-20; PMID:26124675; http://dx.doi.org/10.2147/IJGM.S75189
-
(2015)
Int J Gen Med
, vol.8
, pp. 215-220
-
-
Sarazin, M.1
Roberton, F.2
Charles, R.3
Falchi, A.4
Chiappe, S.G.5
Blanchon, T.6
Lucht, F.7
Hanslik, T.8
-
30
-
-
84876000191
-
Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort
-
23487373
-
M.A.Witt, L.Arias, P.H.Katz, E.T.Truong, D.J.Witt. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013; 56:1248-54; PMID:23487373; http://dx.doi.org/10.1093/cid/cit046
-
(2013)
Clin Infect Dis
, vol.56
, pp. 1248-1254
-
-
Witt, M.A.1
Arias, L.2
Katz, P.H.3
Truong, E.T.4
Witt, D.J.5
-
31
-
-
80051770333
-
Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005–2007
-
21459173
-
B.L.Miller, K.Kretsinger, G.L.Euler, P.J.Lu, F.Ahmed. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005–2007. Vaccine 2011; 29:3850-6; PMID:21459173; http://dx.doi.org/10.1016/j.vaccine.2011.03.058
-
(2011)
Vaccine
, vol.29
, pp. 3850-3856
-
-
Miller, B.L.1
Kretsinger, K.2
Euler, G.L.3
Lu, P.J.4
Ahmed, F.5
-
36
-
-
84978620842
-
-
April
-
FDA. Human Papillomavirus 9-valent Vaccine, Recombinant. 2014. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm426445.htm. Accessed on April17, 2015.
-
(2014)
Human Papillomavirus 9-valent Vaccine, Recombinant
-
-
-
37
-
-
84928216017
-
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
-
25744474
-
M.Drolet, E.Benard, M.C.Boily, H.Ali, L.Baandrup, H.Bauer, S.Beddows, J.Brisson, J.M.Brotherton, T.Cummings, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15:565-80; PMID:25744474; http://dx.doi.org/10.1016/S1473-3099(14)71073-4
-
(2015)
Lancet Infect Dis
, vol.15
, pp. 565-580
-
-
Drolet, M.1
Benard, E.2
Boily, M.C.3
Ali, H.4
Baandrup, L.5
Bauer, H.6
Beddows, S.7
Brisson, J.8
Brotherton, J.M.9
Cummings, T.10
-
38
-
-
79959765563
-
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
-
21629249
-
X.Castellsague, N.Munoz, P.Pitisuttithum, D.Ferris, J.Monsonego, K.Ault, J.Luna, E.Myers, S.Mallary, O.M.Bautista, et al. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. Br J Cancer 2011;105:28-37; PMID:21629249; http://dx.doi.org/10.1038/bjc.2011.185
-
(2011)
Br J Cancer
, vol.105
, pp. 28-37
-
-
Castellsague, X.1
Munoz, N.2
Pitisuttithum, P.3
Ferris, D.4
Monsonego, J.5
Ault, K.6
Luna, J.7
Myers, E.8
Mallary, S.9
Bautista, O.M.10
-
39
-
-
66149161654
-
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
-
19493565
-
N.Munoz, R.Manalastas, Jr., P.Pitisuttithum, D.Tresukosol, J.Monsonego, K.Ault, C.Clavel, J.Luna, E.Myers, S.Hood, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial. Lancet 2009; 373:1949-57; PMID:19493565; http://dx.doi.org/10.1016/S0140-6736(09)60691-7
-
(2009)
Lancet
, vol.373
, pp. 1949-1957
-
-
Munoz, N.1
Manalastas, R.2
Pitisuttithum, P.3
Tresukosol, D.4
Monsonego, J.5
Ault, K.6
Clavel, C.7
Luna, J.8
Myers, E.9
Hood, S.10
-
40
-
-
84876206641
-
A review of clinical trials of human papillomavirus prophylactic vaccines
-
23199956
-
J.T.Schiller, X.Castellsague, S.M.Garland. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30(Suppl. 5):F123-38; PMID:23199956; http://dx.doi.org/10.1016/j.vaccine.2012.04.108
-
(2012)
Vaccine
, vol.30
, pp. F123-F138
-
-
Schiller, J.T.1
Castellsague, X.2
Garland, S.M.3
-
41
-
-
84919383856
-
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
-
25189358
-
S.R.Skinner, A.Szarewski, B.Romanowski, S.M.Garland, E.Lazcano-Ponce, J.Salmeron, M.R.Del Rosario-Raymundo, R.H.Verheijen, S.C.Quek, D.P.da Silva, et al. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Lancet 2014; 384:2213-27; PMID:25189358; http://dx.doi.org/10.1016/S0140-6736(14)60920-X
-
(2014)
Lancet
, vol.384
, pp. 2213-2227
-
-
Skinner, S.R.1
Szarewski, A.2
Romanowski, B.3
Garland, S.M.4
Lazcano-Ponce, E.5
Salmeron, J.6
Del Rosario-Raymundo, M.R.7
Verheijen, R.H.8
Quek, S.C.9
da Silva, D.P.10
-
42
-
-
84866662842
-
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica
-
22586631
-
R.Herrero, S.Wacholder, A.C.Rodriguez, D.Solomon, P.Gonzalez, A.R.Kreimer, C.Porras, J.Schussler, S.Jiménez, M.E.Sherman, et al. Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov 2011; 1:408-19; PMID:22586631; http://dx.doi.org/10.1158/2159-8290.CD-11-0131
-
(2011)
Cancer Discov
, vol.1
, pp. 408-419
-
-
Herrero, R.1
Wacholder, S.2
Rodriguez, A.C.3
Solomon, D.4
Gonzalez, P.5
Kreimer, A.R.6
Porras, C.7
Schussler, J.8
Jiménez, S.9
Sherman, M.E.10
-
43
-
-
84876008961
-
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study
-
23486550
-
A.Leval, E.Herweijer, A.Ploner, S.Eloranta, J.Fridman Simard, J.Dillner, C.Young, E.Netterlid, P.Sparén, L.Arnheim-Dahlström. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst 2013; 105:469-74; PMID:23486550; http://dx.doi.org/10.1093/jnci/djt032
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 469-474
-
-
Leval, A.1
Herweijer, E.2
Ploner, A.3
Eloranta, S.4
Fridman Simard, J.5
Dillner, J.6
Young, C.7
Netterlid, E.8
Sparén, P.9
Arnheim-Dahlström, L.10
-
44
-
-
79551558109
-
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
-
21288094
-
A.R.Giuliano, J.M.Palefsky, S.Goldstone, E.D.Moreira, Jr., M.E.Penny, C.Aranda, E.Vardas, H.Moi, H.Jessen, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364:401-11; PMID:21288094; http://dx.doi.org/10.1056/NEJMoa0909537
-
(2011)
N Engl J Med
, vol.364
, pp. 401-411
-
-
Giuliano, A.R.1
Palefsky, J.M.2
Goldstone, S.3
Moreira, E.D.4
Penny, M.E.5
Aranda, C.6
Vardas, E.7
Moi, H.8
Jessen, H.9
-
45
-
-
84900556843
-
Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
23760231, Erratum in: MMWR Recomm Rep 2015; 64:259
-
H.Q.McLean, A.P.Fiebelkorn, J.L.Temte, G.S.Wallace. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-04):1-34; PMID:23760231. Erratum in: MMWR Recomm Rep 2015; 64:259.
-
(2013)
MMWR Recomm Rep
, vol.62
, Issue.RR-04
, pp. 1-34
-
-
McLean, H.Q.1
Fiebelkorn, A.P.2
Temte, J.L.3
Wallace, G.S.4
-
46
-
-
84908388693
-
Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: analysis of claims-based databases, 2006–2010
-
25424956
-
G.Krishnarajah, C.Carroll, J.Priest, B.Arondekar, S.Burstin, M.Levin. Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: analysis of claims-based databases, 2006–2010. Hum Vaccin Immunother 2014; 10:2460-7; PMID:25424956; http://dx.doi.org/10.4161/hv.29303
-
(2014)
Hum Vaccin Immunother
, vol.10
, pp. 2460-2467
-
-
Krishnarajah, G.1
Carroll, C.2
Priest, J.3
Arondekar, B.4
Burstin, S.5
Levin, M.6
-
47
-
-
34848839208
-
Field effectiveness of vaccination against tick-borne encephalitis
-
17869389
-
F.X.Heinz, H.Holzmann, A.Essl, M.Kundi. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 2007; 25:7559-67; PMID:17869389; http://dx.doi.org/10.1016/j.vaccine.2007.08.024
-
(2007)
Vaccine
, vol.25
, pp. 7559-7567
-
-
Heinz, F.X.1
Holzmann, H.2
Essl, A.3
Kundi, M.4
-
48
-
-
0037375164
-
TBE vaccination and the Austrian experience
-
12628814
-
C.Kunz. TBE vaccination and the Austrian experience. Vaccine 2003; 21 (Suppl. 1):S50-5; PMID:12628814; http://dx.doi.org/10.1016/S0264-410X(02)00813-7
-
(2003)
Vaccine
, vol.21
, pp. S50-S55
-
-
Kunz, C.1
-
49
-
-
84874738300
-
Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)
-
23291941
-
D.Zavadska, I.Anca, F.André, M.Bakir, R.Chlibek, M.Cižman, I.Ivaskeviciene, A.Mangarov, Z.Mészner, M.Pokorn, et al. Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG). Hum Vaccin Immunother 2013; 9:362-74; PMID:23291941; http://dx.doi.org/10.4161/hv.22766
-
(2013)
Hum Vaccin Immunother
, vol.9
, pp. 362-374
-
-
Zavadska, D.1
Anca, I.2
André, F.3
Bakir, M.4
Chlibek, R.5
Cižman, M.6
Ivaskeviciene, I.7
Mangarov, A.8
Mészner, Z.9
Pokorn, M.10
-
50
-
-
79958836540
-
Vaccines against tick-borne encephalitis: WHO position paper
-
21661276
-
World Health Organization (WHO). Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec 2011; 86:241-56; PMID:21661276
-
(2011)
Wkly Epidemiol Rec
, vol.86
, pp. 241-256
-
-
-
51
-
-
84978615744
-
Gerontological Nursing & Healthy Aging Geriatric Nursing & Healthy Aging
-
4th, Elsevier, Philadelphia, PEN, USA:
-
E.G.Lakatta, R.Sloane. Gerontological Nursing & Healthy Aging Geriatric Nursing & Healthy Aging. In:, Ebersole & Hess 4th Edition 2001; Elsevier Philadelphia, PEN, USA.
-
(2001)
Ebersole & Hess
-
-
Lakatta, E.G.1
Sloane, R.2
-
52
-
-
84874422422
-
Frailty in elderly people
-
23395245
-
A.Clegg, J.Young, S.Iliffe, M.O.Rikkert, K.Rockwood. Frailty in elderly people. Lancet 2013; 381:752-62; PMID:23395245; http://dx.doi.org/10.1016/S0140-6736(12)62167-9
-
(2013)
Lancet
, vol.381
, pp. 752-762
-
-
Clegg, A.1
Young, J.2
Iliffe, S.3
Rikkert, M.O.4
Rockwood, K.5
-
53
-
-
84878316328
-
The gracefully aging immune system
-
23677590
-
D.Boraschi, M.T.Aguado, C.Dutel, J.Goronzy, J.Louis, B.Grubeck-Loebenstein, R.Rappuoli, G.Del Giudice. The gracefully aging immune system. Sci Transl Med 2013; 5:185ps8; PMID:23677590; http://dx.doi.org/10.1126/scitranslmed.3005624
-
(2013)
Sci Transl Med
, vol.5
, pp. 185ps8
-
-
Boraschi, D.1
Aguado, M.T.2
Dutel, C.3
Goronzy, J.4
Louis, J.5
Grubeck-Loebenstein, B.6
Rappuoli, R.7
Del Giudice, G.8
-
54
-
-
0036840992
-
Ageing and infection
-
12409046
-
G.Gavazzi, K.H.Krause. Ageing and infection. Lancet Infect Dis 2002; 2:659-66; PMID:12409046; http://dx.doi.org/10.1016/S1473-3099(02)00437-1
-
(2002)
Lancet Infect Dis
, vol.2
, pp. 659-666
-
-
Gavazzi, G.1
Krause, K.H.2
-
55
-
-
66249135655
-
Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region
-
19415978
-
J.P.Michel, C.Chidiac, B.Grubeck-Loebenstein, R.W.Johnson, P.H.Lambert, S.Maggi, R.Moulias, K.Nicholson, H.Werner. Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region. Rejuvenation Res 2009; 12:127-135; PMID:19415978; http://dx.doi.org/10.1089/rej.2008.0813
-
(2009)
Rejuvenation Res
, vol.12
, pp. 127-135
-
-
Michel, J.P.1
Chidiac, C.2
Grubeck-Loebenstein, B.3
Johnson, R.W.4
Lambert, P.H.5
Maggi, S.6
Moulias, R.7
Nicholson, K.8
Werner, H.9
-
56
-
-
84904541204
-
Vaccination in the elderly: what can be recommended?
-
24928553
-
P.O.Lang, R.Aspinall. Vaccination in the elderly: what can be recommended? Drugs Aging 2014; 31:581-99; PMID:24928553; http://dx.doi.org/10.1007/s40266-014-0193-1
-
(2014)
Drugs Aging
, vol.31
, pp. 581-599
-
-
Lang, P.O.1
Aspinall, R.2
-
57
-
-
51449118699
-
Efficacy and effectiveness of influenza vaccination
-
19230153
-
K.L.Nichol. Efficacy and effectiveness of influenza vaccination. Vaccine 2008; 26 Suppl. 4:D17-22; PMID:19230153; http://dx.doi.org/10.1016/j.vaccine.2008.07.048
-
(2008)
Vaccine
, vol.26
, pp. D17-D22
-
-
Nichol, K.L.1
-
58
-
-
77950961240
-
Vaccines for preventing influenza in the elderly
-
20166072
-
T.Jefferson, C.Di Pietrantonj, L.A.Al-Ansary, E.Ferroni, S.Thorning, R.E.Thomas. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; 2:CD004876; PMID:20166072
-
(2010)
Cochrane Database Syst Rev
, vol.2
, pp. CD004876
-
-
Jefferson, T.1
Di Pietrantonj, C.2
Al-Ansary, L.A.3
Ferroni, E.4
Thorning, S.5
Thomas, R.E.6
-
59
-
-
84155162558
-
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
-
22032844
-
M.T.Osterholm, N.S.Kelley, A.Sommer, E.A.Belongia. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/S1473-3099(11)70295-X
-
(2012)
Lancet Infect Dis
, vol.12
, pp. 36-44
-
-
Osterholm, M.T.1
Kelley, N.S.2
Sommer, A.3
Belongia, E.A.4
-
60
-
-
0028022941
-
Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial
-
7839722
-
T.M.Govaert, M.J.Sprenger, G.J.Dinant, K.Aretz, N.Masurel, J.A.Knottnerus. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994; 12:1185-9; PMID:7839722; http://dx.doi.org/10.1016/0264-410X(94)90241-0
-
(1994)
Vaccine
, vol.12
, pp. 1185-1189
-
-
Govaert, T.M.1
Sprenger, M.J.2
Dinant, G.J.3
Aretz, K.4
Masurel, N.5
Knottnerus, J.A.6
-
61
-
-
8144231260
-
Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial
-
15542184
-
S.Allsup, A.Haycox, M.Regan, M.Gosney. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine 2004; 23:639-45; PMID:15542184
-
(2004)
Vaccine
, vol.23
, pp. 639-645
-
-
Allsup, S.1
Haycox, A.2
Regan, M.3
Gosney, M.4
-
62
-
-
84925284620
-
Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010
-
25201438
-
J.S.Lee, W.Nsa, L.R.Hausmann, A.N.Trivedi, D.W.Bratzler, D.Auden, M.K.Mor, K.Baus, F.M.Larbi, M.J.Fine. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med 2014; 174:1806-14; PMID:25201438; http://dx.doi.org/10.1001/jamainternmed.2014.4501
-
(2014)
JAMA Intern Med
, vol.174
, pp. 1806-1814
-
-
Lee, J.S.1
Nsa, W.2
Hausmann, L.R.3
Trivedi, A.N.4
Bratzler, D.W.5
Auden, D.6
Mor, M.K.7
Baus, K.8
Larbi, F.M.9
Fine, M.J.10
-
63
-
-
84907215714
-
Certification of mobile apps for health care
-
25226486
-
S.R.Chan, S.Misra. Certification of mobile apps for health care. JAMA 2014; 312:1155-6; PMID:25226486; http://dx.doi.org/10.1001/jama.2014.9002
-
(2014)
JAMA
, vol.312
, pp. 1155-1156
-
-
Chan, S.R.1
Misra, S.2
-
65
-
-
84887607325
-
Cochrane re-arranged: support for policies to vaccinate elderly people against influenza
-
24095882
-
W.E.Beyer, J.McElhaney, D.J.Smith, A.S.Monto, J.S.Nguyen-Van-Tam, A.D.Osterhaus. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 2013; 31:6030-3; PMID:24095882; http://dx.doi.org/10.1016/j.vaccine.2013.09.063
-
(2013)
Vaccine
, vol.31
, pp. 6030-6033
-
-
Beyer, W.E.1
McElhaney, J.2
Smith, D.J.3
Monto, A.S.4
Nguyen-Van-Tam, J.S.5
Osterhaus, A.D.6
-
66
-
-
84906232635
-
Efficacy of high-dose versus standard-dose influenza vaccine in older adults
-
25119609
-
C.A.DiazGranados, A.J.Dunning, M.Kimmel, D.Kirby, J.Treanor, A.Collins, R.Pollak, J.Christoff, J.Earl, V.Landolfi, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371:635-45; PMID:25119609; http://dx.doi.org/10.1056/NEJMoa1315727
-
(2014)
N Engl J Med
, vol.371
, pp. 635-645
-
-
DiazGranados, C.A.1
Dunning, A.J.2
Kimmel, M.3
Kirby, D.4
Treanor, J.5
Collins, A.6
Pollak, R.7
Christoff, J.8
Earl, J.9
Landolfi, V.10
-
67
-
-
84906658966
-
Vaccines, new opportunities for a new society
-
25136130
-
R.Rappuoli, M.Pizza, G.Del Giudice, E.De Gregorio. Vaccines, new opportunities for a new society. Proc Natl Acad Sci U S A 2014; 111:12288-93; PMID:25136130; http://dx.doi.org/10.1073/pnas.1402981111
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 12288-12293
-
-
Rappuoli, R.1
Pizza, M.2
Del Giudice, G.3
De Gregorio, E.4
-
68
-
-
67651026829
-
Influenza control in the 21st century: optimizing protection of older adults
-
19559118
-
A.S.Monto, F.Ansaldi, R.Aspinall, J.E.McElhaney, L.F.Montaño, K.L.Nichol, J.Puig-Barberà, J.Schmitt, I.Stephenson. Influenza control in the 21st century: optimizing protection of older adults. Vaccine 2009; 27:5043-53; PMID:19559118; http://dx.doi.org/10.1016/j.vaccine.2009.06.032
-
(2009)
Vaccine
, vol.27
, pp. 5043-5053
-
-
Monto, A.S.1
Ansaldi, F.2
Aspinall, R.3
McElhaney, J.E.4
Montaño, L.F.5
Nichol, K.L.6
Puig-Barberà, J.7
Schmitt, J.8
Stephenson, I.9
-
69
-
-
84893164380
-
What are the most important infectious diseases among those ≥65 years: a comprehensive analysis on notifiable diseases, Norway, 1993–2011
-
24495775
-
A.Steens, H.M.Eriksen, H.Blystad. What are the most important infectious diseases among those ≥65 years: a comprehensive analysis on notifiable diseases, Norway, 1993–2011. BMC Infect Dis 2014; 14:57; PMID:24495775; http://dx.doi.org/10.1186/1471-2334-14-57
-
(2014)
BMC Infect Dis
, vol.14
, pp. 57
-
-
Steens, A.1
Eriksen, H.M.2
Blystad, H.3
-
70
-
-
77952095792
-
Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan
-
20108017
-
W.H.Liao, S.H.Lin, C.C.Lai, C.K.Tan, C.H.Liao, Y.T.Huang, C.Y.Wang, P.R.Hsueh. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis 2010; 29:489-92; PMID:20108017; http://dx.doi.org/10.1007/s10096-010-0873-7
-
(2010)
Eur J Clin Microbiol Infect Dis
, vol.29
, pp. 489-492
-
-
Liao, W.H.1
Lin, S.H.2
Lai, C.C.3
Tan, C.K.4
Liao, C.H.5
Huang, Y.T.6
Wang, C.Y.7
Hsueh, P.R.8
-
71
-
-
67651097736
-
Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients
-
19345448
-
A.S.Delelis-Fanien, F.Séité, M.Priner, M.Paccalin. Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients. Rev Med Interne 2009; 30:656-63; PMID:19345448; http://dx.doi.org/10.1016/j.revmed.2008.12.026
-
(2009)
Rev Med Interne
, vol.30
, pp. 656-663
-
-
Delelis-Fanien, A.S.1
Séité, F.2
Priner, M.3
Paccalin, M.4
-
72
-
-
0032776804
-
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity
-
10476727
-
S.Romero-Steiner, D.M.Musher, M.S.Cetron, L.B.Pais, J.E.Groover, A.E.Fiore, B.D.Plikaytis, G.M.Carlone. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999; 29:281-8; PMID:10476727; http://dx.doi.org/10.1086/520200
-
(1999)
Clin Infect Dis
, vol.29
, pp. 281-288
-
-
Romero-Steiner, S.1
Musher, D.M.2
Cetron, M.S.3
Pais, L.B.4
Groover, J.E.5
Fiore, A.E.6
Plikaytis, B.D.7
Carlone, G.M.8
-
73
-
-
0343329899
-
Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial
-
9382120
-
I.Koivula, M.Stén, M.Leinonen, P.H.Mäkelä. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med 1997; 103:281-290; PMID:9382120; http://dx.doi.org/10.1016/S0002-9343(97)00149-6
-
(1997)
Am J Med
, vol.103
, pp. 281-290
-
-
Koivula, I.1
Stén, M.2
Leinonen, M.3
Mäkelä, P.H.4
-
74
-
-
0346594413
-
Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group
-
9482293
-
A.Ortqvist, J.Hedlund, L.A.Burman, E.Elbel, M.Höfer, M.Leinonen, I.Lindblad, B.Sundelöf, M.Kalin. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 1998; 351:399-403; PMID:9482293; http://dx.doi.org/10.1016/S0140-6736(97)07358-3
-
(1998)
Lancet
, vol.351
, pp. 399-403
-
-
Ortqvist, A.1
Hedlund, J.2
Burman, L.A.3
Elbel, E.4
Höfer, M.5
Leinonen, M.6
Lindblad, I.7
Sundelöf, B.8
Kalin, M.9
-
75
-
-
77949395981
-
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial
-
20211953
-
T.Maruyama, O.Taguchi, M.S.Niederman, J.Morser, H.Kobayashi, T.Kobayashi, C.D'Alessandro-Gabazza, S.Nakayama, K.Nishikubo, T.Noguchi, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010; 340:c1004; PMID:20211953; http://dx.doi.org/10.1136/bmj.c1004
-
(2010)
BMJ
, vol.340
, pp. c1004
-
-
Maruyama, T.1
Taguchi, O.2
Niederman, M.S.3
Morser, J.4
Kobayashi, H.5
Kobayashi, T.6
D'Alessandro-Gabazza, C.7
Nakayama, S.8
Nishikubo, K.9
Noguchi, T.10
-
76
-
-
1542711374
-
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
-
15065822
-
B.Christenson, J.Hedlund, P.Lundbergh, A.Ortqvist. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004; 23:363-8; PMID:15065822; http://dx.doi.org/10.1183/09031936.04.00063504
-
(2004)
Eur Respir J
, vol.23
, pp. 363-368
-
-
Christenson, B.1
Hedlund, J.2
Lundbergh, P.3
Ortqvist, A.4
-
77
-
-
44249108338
-
Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity
-
18442371
-
B.Christenson, K.Pauksen, S.P.Sylvan. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J 2008; 5:52; PMID:18442371; http://dx.doi.org/10.1186/1743-422X-5-52
-
(2008)
Virol J
, vol.5
, pp. 52
-
-
Christenson, B.1
Pauksen, K.2
Sylvan, S.P.3
-
78
-
-
84880723200
-
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
-
23688527
-
L.A.Jackson, A.Gurtman, K.Rice, K.Pauksens, R.N.Greenberg, T.R.Jones, D.A.Scott, E.A.Emini, W.C.Gruber, B.Schmoele-Thoma. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 2013; 31:3585-93; PMID:23688527; http://dx.doi.org/10.1016/j.vaccine.2013.05.010
-
(2013)
Vaccine
, vol.31
, pp. 3585-3593
-
-
Jackson, L.A.1
Gurtman, A.2
Rice, K.3
Pauksens, K.4
Greenberg, R.N.5
Jones, T.R.6
Scott, D.A.7
Emini, E.A.8
Gruber, W.C.9
Schmoele-Thoma, B.10
-
79
-
-
84897492959
-
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age
-
24606865
-
R.N.Greenberg, A.Gurtman, R.W.Frenck, C.Strout, K.U.Jansen, J.Trammel, D.A.Scott, E.A.Emini, W.C.Gruber, B.Schmoele-Thoma. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age. Vaccine 2014; 32:2364-74; PMID:24606865; http://dx.doi.org/10.1016/j.vaccine.2014.02.002
-
(2014)
Vaccine
, vol.32
, pp. 2364-2374
-
-
Greenberg, R.N.1
Gurtman, A.2
Frenck, R.W.3
Strout, C.4
Jansen, K.U.5
Trammel, J.6
Scott, D.A.7
Emini, E.A.8
Gruber, W.C.9
Schmoele-Thoma, B.10
-
80
-
-
84901596757
-
ECDC country experts for pneumococcal disease. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era
-
Can't
-
A.Navarro Torné, J.G.Dias, C.Quinten, F.Hruba, M.C.Busana, P.L.Lopalco, A.J.Gauci, L.Pastore-Celentano. ECDC country experts for pneumococcal disease. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. Vaccine 2014; 32:3644-50; PMID:Can't; http://dx.doi.org/10.1016/j.vaccine.2014.04.066
-
(2014)
Vaccine
, vol.32
, pp. 3644-3650
-
-
Navarro Torné, A.1
Dias, J.G.2
Quinten, C.3
Hruba, F.4
Busana, M.C.5
Lopalco, P.L.6
Gauci, A.J.7
Pastore-Celentano, L.8
-
81
-
-
84874595165
-
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): a guide to its use in older adults
-
23038610
-
L.J.Scott, M.Sanford. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): a guide to its use in older adults. Drugs Aging 2012; 29:847-55; PMID:23038610; http://dx.doi.org/10.1007/s40266-012-0017-0
-
(2012)
Drugs Aging
, vol.29
, pp. 847-855
-
-
Scott, L.J.1
Sanford, M.2
-
82
-
-
84925344388
-
Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP); ACIP Adult Immunization Work Group. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older–United States, 2015
-
25654609
-
D.K.Kim, C.B.Bridges, K.H.Harriman. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP); ACIP Adult Immunization Work Group. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older–United States, 2015. MMWR Morb Mortal Wkly Rep 2015; 64:91-2; PMID:25654609
-
(2015)
MMWR Morb Mortal Wkly Rep
, vol.64
, pp. 91-92
-
-
Kim, D.K.1
Bridges, C.B.2
Harriman, K.H.3
-
83
-
-
84887510416
-
Pertussis: a reemerging infection
-
24364571, Erratum in Am Fam Physician 2014; 89:317
-
J.M.Kline, W.D.Lewis, E.A.Smith, L.R.Tracy, S.K.Moerschel. Pertussis: a reemerging infection. Am Fam Physician 2013; 88:507-14; PMID:24364571 Erratum in Am Fam Physician 2014; 89:317.
-
(2013)
Am Fam Physician
, vol.88
, pp. 507-514
-
-
Kline, J.M.1
Lewis, W.D.2
Smith, E.A.3
Tracy, L.R.4
Moerschel, S.K.5
-
84
-
-
84876117065
-
Assessment of vaccine candidates for persons aged 50 and older: a review
-
23586926
-
R.Eilers, P.F.Krabbe, T.G.van Essen, A.Suijkerbuijk, A.van Lier, H.E.de Melker. Assessment of vaccine candidates for persons aged 50 and older: a review. BMC Geriatr 2013; 13:32; PMID:23586926; http://dx.doi.org/10.1186/1471-2318-13-32
-
(2013)
BMC Geriatr
, vol.13
, pp. 32
-
-
Eilers, R.1
Krabbe, P.F.2
van Essen, T.G.3
Suijkerbuijk, A.4
van Lier, A.5
de Melker, H.E.6
-
85
-
-
84874429202
-
Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial
-
23313654
-
U.Zimmermann, G.Gavazzi, P.Richard, C.Eymin, B.Soubeyrand, M.Baudin. Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial. Vaccine 2013; 31:1496-502; PMID:23313654; http://dx.doi.org/10.1016/j.vaccine.2012.12.081
-
(2013)
Vaccine
, vol.31
, pp. 1496-1502
-
-
Zimmermann, U.1
Gavazzi, G.2
Richard, P.3
Eymin, C.4
Soubeyrand, B.5
Baudin, M.6
-
86
-
-
84872312670
-
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
-
23196953
-
H.F.Tseng, L.S.Sy, L.Qian, S.M.Marcy, L.A.Jackson, J.Glanz, J.Nordin, R.Baxter, A.Naleway, J.Donahue, et al. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis 2013; 56:315-21; PMID:23196953; http://dx.doi.org/10.1093/cid/cis871
-
(2013)
Clin Infect Dis
, vol.56
, pp. 315-321
-
-
Tseng, H.F.1
Sy, L.S.2
Qian, L.3
Marcy, S.M.4
Jackson, L.A.5
Glanz, J.6
Nordin, J.7
Baxter, R.8
Naleway, A.9
Donahue, J.10
-
87
-
-
84921433083
-
Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine
-
Can't
-
M.R.Sala-Farré, C.Arias-Varela, A.Recasens-Recasens, M.Simó-Sanahuja, C.Muñoz-Almagro, J.Pérez-Jové. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine. Enferm Infecc Microbiol Clin 2015; 33:27-31; PMID:Can't; http://dx.doi.org/10.1016/j.eimc.2013.09.013
-
(2015)
Enferm Infecc Microbiol Clin
, vol.33
, pp. 27-31
-
-
Sala-Farré, M.R.1
Arias-Varela, C.2
Recasens-Recasens, A.3
Simó-Sanahuja, M.4
Muñoz-Almagro, C.5
Pérez-Jové, J.6
-
88
-
-
21144448596
-
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
-
15930418
-
M.N.Oxman, M.J.Levin, G.R.Johnson, K.E.Schmader, S.E.Straus, L.D.Gelb, R.D.Arbeit, M.S.Simberkoff, A.A.Gershon, L.E.Davis, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84; PMID:15930418; http://dx.doi.org/10.1056/NEJMoa051016
-
(2005)
N Engl J Med
, vol.352
, pp. 2271-2284
-
-
Oxman, M.N.1
Levin, M.J.2
Johnson, G.R.3
Schmader, K.E.4
Straus, S.E.5
Gelb, L.D.6
Arbeit, R.D.7
Simberkoff, M.S.8
Gershon, A.A.9
Davis, L.E.10
-
90
-
-
84876897193
-
Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study
-
23585738
-
S.M.Langan, L.Smeeth, D.J.Margolis, S.L.Thomas. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med 2013; 10:e1001420; PMID:23585738; http://dx.doi.org/10.1371/journal.pmed.1001420
-
(2013)
PLoS Med
, vol.10
, pp. e1001420
-
-
Langan, S.M.1
Smeeth, L.2
Margolis, D.J.3
Thomas, S.L.4
-
91
-
-
84868013968
-
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy
-
22828595
-
K.E.Schmader, M.N.Oxman, M.J.Levin, G.Johnson, J.H.Zhang, R.Betts, V.A.Morrison, L.Gelb, J.C.Guatelli, R.Harbecke, et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis 2012; 55:1320-8; PMID:22828595; http://dx.doi.org/10.1093/cid/cis638
-
(2012)
Clin Infect Dis
, vol.55
, pp. 1320-1328
-
-
Schmader, K.E.1
Oxman, M.N.2
Levin, M.J.3
Johnson, G.4
Zhang, J.H.5
Betts, R.6
Morrison, V.A.7
Gelb, L.8
Guatelli, J.C.9
Harbecke, R.10
-
92
-
-
84906671300
-
-
London, UK: European Medicines Agency, September
-
Merck Sharp & Dohme Corp. Zostavax: European public assessment reports—product information. London, UK: European Medicines Agency; 2013. Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000674/ WC500053462.pdf. Accessed on: September14, 2015.
-
(2013)
Zostavax: European public assessment reports—product information
-
-
-
93
-
-
84866916280
-
A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults
-
22872734
-
I.Leroux-Roels, G.Leroux-Roels, F.Clement, P.Vandepapelière, V.Vassilev, E.Ledent, T.C.Heineman. A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults. J Infect Dis 2012; 206:1280-90; PMID:22872734; http://dx.doi.org/10.1093/infdis/jis497
-
(2012)
J Infect Dis
, vol.206
, pp. 1280-1290
-
-
Leroux-Roels, I.1
Leroux-Roels, G.2
Clement, F.3
Vandepapelière, P.4
Vassilev, V.5
Ledent, E.6
Heineman, T.C.7
-
94
-
-
84941560921
-
HIV resistance testing and detected drug resistance in Europe
-
26091300
-
A.Schultze, A.N.Phillips, R.Paredes, M.Battegay, J.K.Rockstroh, L.Machala, J.Tomazic, P.M.Girard, I.Januskevica, K.Gronborg-Laut, et al. HIV resistance testing and detected drug resistance in Europe. AIDS 2015; 29:1379-89; PMID:26091300; http://dx.doi.org/10.1097/QAD.0000000000000708
-
(2015)
AIDS
, vol.29
, pp. 1379-1389
-
-
Schultze, A.1
Phillips, A.N.2
Paredes, R.3
Battegay, M.4
Rockstroh, J.K.5
Machala, L.6
Tomazic, J.7
Girard, P.M.8
Januskevica, I.9
Gronborg-Laut, K.10
-
95
-
-
84946568192
-
The detection of rheumatic disease through hospital diagnoses with examples of rheumatoid arthritis and giant cell arteritis: what are we missing?
-
Epub Aug 1, 26233503
-
C.J.Michet3rd, C.S.Crowson, S.J.Achenbach, E.L.Matteson. The detection of rheumatic disease through hospital diagnoses with examples of rheumatoid arthritis and giant cell arteritis: what are we missing? J Rheumatol 2015; 42:2071-4; Epub Aug 1; PMID:26233503
-
(2015)
J Rheumatol
, vol.42
, pp. 2071-2074
-
-
Michet, C.J.1
Crowson, C.S.2
Achenbach, S.J.3
Matteson, E.L.4
-
96
-
-
84939215429
-
Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis
-
26101226
-
A.O.Molnar, D.Fergusson, A.K.Tsampalieros, A.Bennett, N.Fergusson, T.Ramsay, G.A.Knoll. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ 2015; 350:h3163; PMID:26101226; http://dx.doi.org/10.1136/bmj.h3163
-
(2015)
BMJ
, vol.350
, pp. h3163
-
-
Molnar, A.O.1
Fergusson, D.2
Tsampalieros, A.K.3
Bennett, A.4
Fergusson, N.5
Ramsay, T.6
Knoll, G.A.7
-
97
-
-
84900325191
-
Immunocompromised patients: review of the most common infections happened in 446 hospitalized patients
-
25002900
-
M.Meidani, A.E.Naeini, M.Rostami, R.Sherkat, K.Tayeri. Immunocompromised patients: review of the most common infections happened in 446 hospitalized patients. J Res Med Sci 2014; 19 (Suppl. 1):S71-3; PMID:25002900
-
(2014)
J Res Med Sci
, vol.19
, pp. S71-S73
-
-
Meidani, M.1
Naeini, A.E.2
Rostami, M.3
Sherkat, R.4
Tayeri, K.5
-
98
-
-
84922249490
-
Vaccine use in primary immunodeficiency disorders
-
24837766
-
N.Principi, S.Esposito. Vaccine use in primary immunodeficiency disorders. Vaccine 2014; 32:3725-31; PMID:24837766; http://dx.doi.org/10.1016/j.vaccine.2014.05.022
-
(2014)
Vaccine
, vol.32
, pp. 3725-3731
-
-
Principi, N.1
Esposito, S.2
-
99
-
-
84922612197
-
Vaccine administration in children with chronic kidney disease
-
25275950
-
S.Esposito, M.V.Mastrolia, E.Prada, C.Pietrasanta, N.Principi. Vaccine administration in children with chronic kidney disease. Vaccine 2014; 32:6601-6; PMID:25275950; http://dx.doi.org/10.1016/j.vaccine.2014.09.038
-
(2014)
Vaccine
, vol.32
, pp. 6601-6606
-
-
Esposito, S.1
Mastrolia, M.V.2
Prada, E.3
Pietrasanta, C.4
Principi, N.5
-
100
-
-
84955211647
-
Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine
-
T.M.Souza, M.Santini-Oliveira, A.Martorelli, P.R.Luz, M.T.Vasconcellos, C.B.Giacoia-Gripp, M.Morgado, E.P.Nunes, A.S.Lemos, A.C.Ferreira, et al. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine. J Med Virol 2016; 88:426-436.
-
(2016)
J Med Virol
-
-
Souza, T.M.1
Santini-Oliveira, M.2
Martorelli, A.3
Luz, P.R.4
Vasconcellos, M.T.5
Giacoia-Gripp, C.B.6
Morgado, M.7
Nunes, E.P.8
Lemos, A.S.9
Ferreira, A.C.10
-
101
-
-
84936753771
-
Effect of immunosuppression on T-helper 2 and B-cell responses to influenza vaccination
-
25589334
-
A.Egli, A.Humar, L.A.Widmer, L.F.Lisboa, D.M.Santer, T.Mueller, J.Stelling, A.Baluch, D.O'Shea, M.Houghton, et al. Effect of immunosuppression on T-helper 2 and B-cell responses to influenza vaccination. J Infect Dis 2015; 212:137-46; PMID:25589334; http://dx.doi.org/10.1093/infdis/jiv015
-
(2015)
J Infect Dis
, vol.212
, pp. 137-146
-
-
Egli, A.1
Humar, A.2
Widmer, L.A.3
Lisboa, L.F.4
Santer, D.M.5
Mueller, T.6
Stelling, J.7
Baluch, A.8
O'Shea, D.9
Houghton, M.10
-
102
-
-
77954786625
-
Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990–2002
-
20649965
-
J.M.Langley, L.Dodds, D.Fell, G.R.Langley. Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990–2002. BMC Infect Dis 2010; 10:219; PMID:20649965; http://dx.doi.org/10.1186/1471-2334-10-219
-
(2010)
BMC Infect Dis
, vol.10
, pp. 219
-
-
Langley, J.M.1
Dodds, L.2
Fell, D.3
Langley, G.R.4
-
103
-
-
84983433744
-
Immunization of children with secondary immunodeficiency
-
26176360, Epub Jul 15
-
S.Esposito, E.Prada, M.Lelii, L.Castellazzi. Immunization of children with secondary immunodeficiency. Hum Vaccin Immunother 2015; 11:2564-70; PMID:26176360; Epub Jul 15
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 2564-2570
-
-
Esposito, S.1
Prada, E.2
Lelii, M.3
Castellazzi, L.4
-
104
-
-
84949115726
-
Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults
-
25483530
-
F.Ansaldi, A.Orsi, C.Trucchi, D.De Florentiis, A.Ceravolo, M.Coppelli, S.Schiaffino, V.Turello, R.Rosselli, R.Carloni, et al. Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults. Hum Vaccin Immunother 2015; 11:166-71; PMID:25483530; http://dx.doi.org/10.4161/hv.34419
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 166-171
-
-
Ansaldi, F.1
Orsi, A.2
Trucchi, C.3
De Florentiis, D.4
Ceravolo, A.5
Coppelli, M.6
Schiaffino, S.7
Turello, V.8
Rosselli, R.9
Carloni, R.10
-
105
-
-
84940853464
-
Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
26334788
-
M.Kobayashi, N.M.Bennett, R.Gierke, O.Almendares, M.R.Moore, C.G.Whitney, T.Pilishvili. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015; 64:944-7; PMID:26334788; http://dx.doi.org/10.15585/mmwr.mm6434a4
-
(2015)
MMWR Morb Mortal Wkly Rep
, vol.64
, pp. 944-947
-
-
Kobayashi, M.1
Bennett, N.M.2
Gierke, R.3
Almendares, O.4
Moore, M.R.5
Whitney, C.G.6
Pilishvili, T.7
-
106
-
-
84931834207
-
PCVs in individuals at increased risk of pneumococcal disease: a literature review
-
26083459
-
M.A.Fletcher, P.Balmer, E.Bonnet, N.Dartois. PCVs in individuals at increased risk of pneumococcal disease: a literature review. Expert Rev Vaccines 2015; 14:975-1030; PMID:26083459; http://dx.doi.org/10.1586/14760584.2015.1037743
-
(2015)
Expert Rev Vaccines
, vol.14
, pp. 975-1030
-
-
Fletcher, M.A.1
Balmer, P.2
Bonnet, E.3
Dartois, N.4
-
107
-
-
77950492235
-
Vaccinations in children with cancer
-
20226246
-
S.Esposito, V.Cecinati, L.Brescia, N.Principi. Vaccinations in children with cancer. Vaccine 2010; 28:3278-84; PMID:20226246; http://dx.doi.org/10.1016/j.vaccine.2010.02.096
-
(2010)
Vaccine
, vol.28
, pp. 3278-3284
-
-
Esposito, S.1
Cecinati, V.2
Brescia, L.3
Principi, N.4
-
108
-
-
84951567032
-
Cancer and HIV infection in referral hospitals from four West African countries
-
26375806, Epub Sep 12
-
A.Jaquet, M.Odutola, D.K.Ekouevi, A.Tanon, E.Oga, J.Akakpo, M.Charurat, M.D.Zannou, S.P.Eholie, A.J.Sasco, et al. Cancer and HIV infection in referral hospitals from four West African countries. Cancer Epidemiol 2015; 39:1060-5; PMID:26375806; Epub Sep 12
-
(2015)
Cancer Epidemiol
, vol.39
, pp. 1060-1065
-
-
Jaquet, A.1
Odutola, M.2
Ekouevi, D.K.3
Tanon, A.4
Oga, E.5
Akakpo, J.6
Charurat, M.7
Zannou, M.D.8
Eholie, S.P.9
Sasco, A.J.10
-
109
-
-
84929509772
-
Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices
-
25811679
-
E.Petrosky, J.A.BocchiniJr, S.Hariri, H.Chesson, C.R.Curtis, M.Saraiya, E.R.Unger, L.E.Markowitz. Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015; 64:300-4; PMID:25811679
-
(2015)
MMWR Morb Mortal Wkly Rep
, vol.64
, pp. 300-304
-
-
Petrosky, E.1
Bocchini, J.A.2
Hariri, S.3
Chesson, H.4
Curtis, C.R.5
Saraiya, M.6
Unger, E.R.7
Markowitz, L.E.8
-
110
-
-
51049086126
-
Recommendations for cervical cancer prevention in Asia Pacific
-
18945418
-
S.M.Garland, J.Cuzick, E.J.Domingo, S.J.Goldie, Y.T.Kim, R.Konno, D.M.Parkin, Y.L.Qiao, R.Sankaranarayanan, P.L.Stern, et al. Recommendations for cervical cancer prevention in Asia Pacific. Vaccine 2008; 26(Suppl. 12):M89-98; PMID:18945418; http://dx.doi.org/10.1016/j.vaccine.2008.06.020
-
(2008)
Vaccine
, vol.26
, pp. M89-M98
-
-
Garland, S.M.1
Cuzick, J.2
Domingo, E.J.3
Goldie, S.J.4
Kim, Y.T.5
Konno, R.6
Parkin, D.M.7
Qiao, Y.L.8
Sankaranarayanan, R.9
Stern, P.L.10
-
111
-
-
67849090088
-
Human papillomavirus vaccines and anal carcinoma
-
19339940
-
S.Franceschi, H.De Vuyst. Human papillomavirus vaccines and anal carcinoma. Curr Opin HIV AIDS 2009; 4:57-63; PMID:19339940; http://dx.doi.org/10.1097/COH.0b013e32831b9c81
-
(2009)
Curr Opin HIV AIDS
, vol.4
, pp. 57-63
-
-
Franceschi, S.1
De Vuyst, H.2
-
112
-
-
17144409077
-
Reimmunization after hematopoietic stem cell transplantation
-
15889995
-
C.M.Machado. Reimmunization after hematopoietic stem cell transplantation. Expert Rev Vaccines 2005; 4:219-28; PMID:15889995; http://dx.doi.org/10.1586/14760584.4.2.219
-
(2005)
Expert Rev Vaccines
, vol.4
, pp. 219-228
-
-
Machado, C.M.1
-
113
-
-
84903774307
-
Varicella and herpes zoster vaccines: WHO position paper, June 2014
-
24983077
-
World Health Organization (WHO). Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 2014; 89:265-87; PMID:24983077
-
(2014)
Wkly Epidemiol Rec
, vol.89
, pp. 265-287
-
-
-
114
-
-
84907997133
-
Vaccination recommendations for patients with neuromuscular disease
-
25223270
-
S.Esposito, C.Bruno, A.Berardinelli, M.Filosto, T.Mongini, L.Morandi, O.Musumeci, E.Pegoraro, G.Siciliano, P.Tonin, et al. Vaccination recommendations for patients with neuromuscular disease. Vaccine 2014; 32:5893-900; PMID:25223270; http://dx.doi.org/10.1016/j.vaccine.2014.09.003
-
(2014)
Vaccine
, vol.32
, pp. 5893-5900
-
-
Esposito, S.1
Bruno, C.2
Berardinelli, A.3
Filosto, M.4
Mongini, T.5
Morandi, L.6
Musumeci, O.7
Pegoraro, E.8
Siciliano, G.9
Tonin, P.10
-
115
-
-
84893090976
-
Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients
-
24269706
-
N.C.Issa, F.M.Marty, H.Leblebjian, A.Galar, M.M.Shea, J.H.Antin, R.J.Soiffer, L.R.Baden. Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2014; 20:285-7; PMID:24269706; http://dx.doi.org/10.1016/j.bbmt.2013.11.013
-
(2014)
Biol Blood Marrow Transplant
, vol.20
, pp. 285-287
-
-
Issa, N.C.1
Marty, F.M.2
Leblebjian, H.3
Galar, A.4
Shea, M.M.5
Antin, J.H.6
Soiffer, R.J.7
Baden, L.R.8
-
116
-
-
84860319956
-
Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era
-
22398246
-
E.B.Nix, N.Hawdon, S.Gravelle, B.Biman, M.Brigden, S.Malik, W.McCready, G.Ferroni, M.Ulanova. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era. Clin Vaccine Immunol 2012; 19:766-71; PMID:22398246; http://dx.doi.org/10.1128/CVI.05675-11
-
(2012)
Clin Vaccine Immunol
, vol.19
, pp. 766-771
-
-
Nix, E.B.1
Hawdon, N.2
Gravelle, S.3
Biman, B.4
Brigden, M.5
Malik, S.6
McCready, W.7
Ferroni, G.8
Ulanova, M.9
-
117
-
-
70349560669
-
Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease
-
19779400
-
Centers for Disease Control and Prevention (CDC). Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep 2009; 58:1042-3; PMID:19779400
-
(2009)
MMWR Morb Mortal Wkly Rep
, vol.58
, pp. 1042-1043
-
-
-
118
-
-
84925257832
-
Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals
-
25707692
-
P.Nived, C.S.Jørgensen, B.Settergren. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals. Vaccine 2015; 33:1688-94; PMID:25707692; http://dx.doi.org/10.1016/j.vaccine.2015.02.026
-
(2015)
Vaccine
, vol.33
, pp. 1688-1694
-
-
Nived, P.1
Jørgensen, C.S.2
Settergren, B.3
-
119
-
-
44449125241
-
Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: a review of the evidence and current recommendations
-
19352452
-
J.A.Buxton, J.H.Kim. Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: a review of the evidence and current recommendations. Can J Infect Dis Med Microbiol 2008; 19:197-202; PMID:19352452
-
(2008)
Can J Infect Dis Med Microbiol
, vol.19
, pp. 197-202
-
-
Buxton, J.A.1
Kim, J.H.2
-
120
-
-
84983456209
-
Hepatitis B and A vaccination in HIV-infected adults: a review
-
26208678, Epub Jul 24
-
G.Mena, A.L.García-Basteiro, J.M.Bayas. Hepatitis B and A vaccination in HIV-infected adults: a review. Hum Vaccin Immunother 2015; 11:2582-98; PMID:26208678; Epub Jul 24
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 2582-2598
-
-
Mena, G.1
García-Basteiro, A.L.2
Bayas, J.M.3
-
121
-
-
84955745763
-
CD4/CD8 ratio predicts yellow fever vaccine-induced antibody titers in virologically-suppressed HIV-infected patients
-
71:189-195
-
V.I.Avelino-Silva, K.T.Miyaji, A.Mathias, D.Alves Costa, J.Zanatta de Carvalho, S.B.Lima, M.Simoes, M.S.Freire, H.H.Caiaffa, M.A.Hong, et al. CD4/CD8 ratio predicts yellow fever vaccine-induced antibody titers in virologically-suppressed HIV-infected patients. J Acquir Immune Defic Syndr 2016; 71:189-195.
-
(2016)
J Acquir Immune Defic Syndr
-
-
Avelino-Silva, V.I.1
Miyaji, K.T.2
Mathias, A.3
Alves Costa, D.4
Zanatta de Carvalho, J.5
Lima, S.B.6
Simoes, M.7
Freire, M.S.8
Caiaffa, H.H.9
Hong, M.A.10
-
122
-
-
34250788513
-
Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient
-
17520544
-
M.Kamboj, K.A.Sepkowitz. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient. Infect Control Hosp Epidemiol 2007; 28:702-7; PMID:17520544; http://dx.doi.org/10.1086/517952
-
(2007)
Infect Control Hosp Epidemiol
, vol.28
, pp. 702-707
-
-
Kamboj, M.1
Sepkowitz, K.A.2
-
123
-
-
84867395444
-
Can infants be protected by means of maternal vaccination?
-
22862749
-
S.Esposito, S.Bosis, L.Morlacchi, E.Baggi, C.Sabatini, N.Principi. Can infants be protected by means of maternal vaccination? Clin Microbiol Infect 2012; 18 Suppl. 5:85-92; PMID:22862749; http://dx.doi.org/10.1111/j.1469-0691.2012.03936.x
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 85-92
-
-
Esposito, S.1
Bosis, S.2
Morlacchi, L.3
Baggi, E.4
Sabatini, C.5
Principi, N.6
-
124
-
-
84948118421
-
Maternal immunization - Promises and concerns
-
26263199, Epub Aug 8
-
J.A.Englund. Maternal immunization - Promises and concerns. Vaccine 2015; 33:6372-3; PMID:26263199; Epub Aug 8
-
(2015)
Vaccine
, vol.33
, pp. 6372-6373
-
-
Englund, J.A.1
-
125
-
-
84940725753
-
Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination
-
26238723
-
U.Baum, T.Leino, M.Gissler, T.Kilpi, J.Jokinen. Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination. Vaccine 2015; 33:4850-4857; PMID:26238723; http://dx.doi.org/10.1016/j.vaccine.2015.07.061
-
(2015)
Vaccine
, vol.33
, pp. 4850-4857
-
-
Baum, U.1
Leino, T.2
Gissler, M.3
Kilpi, T.4
Jokinen, J.5
-
126
-
-
84951571153
-
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator
-
26374816, pub Sep 15
-
S.N.Ladhani, N.J.Andrews, J.Southern, C.E.Jones, G.Amirthalingam, P.A.Waight, A.England, M.Matheson, X.Bai, H.Findlow, et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis 2015; 61:1637-44; PMID:26374816; pub Sep 15
-
(2015)
Clin Infect Dis
, vol.61
, pp. 1637-1644
-
-
Ladhani, S.N.1
Andrews, N.J.2
Southern, J.3
Jones, C.E.4
Amirthalingam, G.5
Waight, P.A.6
England, A.7
Matheson, M.8
Bai, X.9
Findlow, H.10
-
127
-
-
84961837204
-
The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States
-
26378718, Epub Sep 17
-
P.L.Moro, M.M.McNeil, L.Sukumaran, K.R.Broder. The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States. Hum Vaccin Immunother 2015; 11:2872-9; PMID:26378718; Epub Sep 17
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 2872-2879
-
-
Moro, P.L.1
McNeil, M.M.2
Sukumaran, L.3
Broder, K.R.4
-
128
-
-
33750389241
-
Pneumococcal vaccination during pregnancy for preventing infant infection
-
25613573
-
S.Chaithongwongwatthana, W.Yamasmit, S.Limpongsanurak, P.Lumbiganon, J.E.Tolosa. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev 2015; 1:CD004903; PMID:25613573
-
(2015)
Cochrane Database Syst Rev
, Issue.1
, pp. CD004903
-
-
Chaithongwongwatthana, S.1
Yamasmit, W.2
Limpongsanurak, S.3
Lumbiganon, P.4
Tolosa, J.E.5
-
129
-
-
84883241853
-
Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom
-
23538521
-
G.Blanchard-Rohner, M.D.Snape, D.F.Kelly, D.O'Connor, T.John, E.Kibwana, H.Parks, K.Ford, P.M.Dull, A.J.Pollard. Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom. Pediatr Infect Dis J 2013; 32:768-76; PMID:23538521; http://dx.doi.org/10.1097/INF.0b013e318292f425
-
(2013)
Pediatr Infect Dis J
, vol.32
, pp. 768-776
-
-
Blanchard-Rohner, G.1
Snape, M.D.2
Kelly, D.F.3
O'Connor, D.4
John, T.5
Kibwana, E.6
Parks, H.7
Ford, K.8
Dull, P.M.9
Pollard, A.J.10
-
130
-
-
84915776207
-
Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines
-
25285883
-
B.Keller-Stanislawski, J.A.Englund, G.Kang, P.Mangtani, K.Neuzil, H.Nohynek, R.Pless, P.Lambach, P.Zuber. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 2014; 32:7057-64; PMID:25285883; http://dx.doi.org/10.1016/j.vaccine.2014.09.052
-
(2014)
Vaccine
, vol.32
, pp. 7057-7064
-
-
Keller-Stanislawski, B.1
Englund, J.A.2
Kang, G.3
Mangtani, P.4
Neuzil, K.5
Nohynek, H.6
Pless, R.7
Lambach, P.8
Zuber, P.9
-
131
-
-
84929611569
-
Effect of hepatitis B vaccination in hepatitis B surface antibody-negative pregnant mothers on the vertical transmission of hepatitis B virus from father to infant
-
26170949
-
L.H.Cao, Y.R.Li, S.Y.Wang, Z.M.Liu, S.C.Sun, D.B.Xu, J.D.Zhang. Effect of hepatitis B vaccination in hepatitis B surface antibody-negative pregnant mothers on the vertical transmission of hepatitis B virus from father to infant. Exp Ther Med 2015; 10:279-84; PMID:26170949
-
(2015)
Exp Ther Med
, vol.10
, pp. 279-284
-
-
Cao, L.H.1
Li, Y.R.2
Wang, S.Y.3
Liu, Z.M.4
Sun, S.C.5
Xu, D.B.6
Zhang, J.D.7
-
132
-
-
84976253969
-
Vaccination of healthcare workers: a review
-
26291642, Epub Aug 20
-
S.Haviari, T.Bénet, M.Saadatian-Elahi, P.André, P.Loulergue, P.Vanhems. Vaccination of healthcare workers: a review. Hum Vaccin Immunother 2015; 11:2522-37; PMID:26291642; Epub Aug 20
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 2522-2537
-
-
Haviari, S.1
Bénet, T.2
Saadatian-Elahi, M.3
André, P.4
Loulergue, P.5
Vanhems, P.6
-
133
-
-
84960950278
-
Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: a 2004–2009 case-test, negative-control, prospective study
-
P.Vanhems, Y.Baghdadi, S.Roche, T.Bénet, C.Regis, B.Lina, O.Robert, N.Voirin, R.Ecochard, S.Amour. Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: a 2004–2009 case-test, negative-control, prospective study. Hum Vaccin Immunother 2016; 12: 485-490.
-
(2016)
Hum Vaccin Immunother
-
-
Vanhems, P.1
Baghdadi, Y.2
Roche, S.3
Bénet, T.4
Regis, C.5
Lina, B.6
Robert, O.7
Voirin, N.8
Ecochard, R.9
Amour, S.10
-
134
-
-
84925938683
-
Implementation of pertussis immunization in health-care personnel
-
25776922
-
K.Walther, M.A.Burckhardt, T.Erb, U.Heininger. Implementation of pertussis immunization in health-care personnel. Vaccine 2015; 33:2009-14; PMID:25776922; http://dx.doi.org/10.1016/j.vaccine.2015.03.013
-
(2015)
Vaccine
, vol.33
, pp. 2009-2014
-
-
Walther, K.1
Burckhardt, M.A.2
Erb, T.3
Heininger, U.4
-
135
-
-
84942983742
-
Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel
-
26138999, Epub Jun 30
-
G.J.Baracco, S.Eisert, S.Saavedra, P.Hirsch, M.Marin, I.R.Ortega-Sanchez. Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel. Am J Infect Control 2015; 43:1053-60; PMID:26138999; Epub Jun 30
-
(2015)
Am J Infect Control
, vol.43
, pp. 1053-1060
-
-
Baracco, G.J.1
Eisert, S.2
Saavedra, S.3
Hirsch, P.4
Marin, M.5
Ortega-Sanchez, I.R.6
-
136
-
-
84949120823
-
Low vaccination coverage among italian healthcare workers in 2013
-
25483526
-
F.Fortunato, S.Tafuri, V.Cozza, D.Martinelli, R.Prato. Low vaccination coverage among italian healthcare workers in 2013. Hum Vaccin Immunother 2015; 11:133-9; PMID:25483526; http://dx.doi.org/10.4161/hv.34415
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 133-139
-
-
Fortunato, F.1
Tafuri, S.2
Cozza, V.3
Martinelli, D.4
Prato, R.5
-
137
-
-
71249106154
-
Immune status and risk perception of acquisition of vaccine preventable diseases among health care workers
-
19608297
-
M.I.Dinelli, T.MoreiraTd, E.R.Paulino, M.C.da Rocha, F.B.Graciani, M.I.de Moraes-Pinto. Immune status and risk perception of acquisition of vaccine preventable diseases among health care workers. Am J Infect Control 2009; 37:858-60; PMID:19608297; http://dx.doi.org/10.1016/j.ajic.2009.04.283
-
(2009)
Am J Infect Control
, vol.37
, pp. 858-860
-
-
Dinelli, M.I.1
Moreira, T.2
Paulino, E.R.3
da Rocha, M.C.4
Graciani, F.B.5
de Moraes-Pinto, M.I.6
-
138
-
-
84940725351
-
Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy
-
26232541
-
M.Hartal, N.Yavnai, I.Galor, E.Avramovich, T.Sela, R.Kayouf, A.Tzurel-Ferber, L.J.Greenberg, T.Halperin, H.Levine. Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy. Vaccine 2015; 33:4878-85; PMID:26232541; http://dx.doi.org/10.1016/j.vaccine.2015.07.058
-
(2015)
Vaccine
, vol.33
, pp. 4878-4885
-
-
Hartal, M.1
Yavnai, N.2
Galor, I.3
Avramovich, E.4
Sela, T.5
Kayouf, R.6
Tzurel-Ferber, A.7
Greenberg, L.J.8
Halperin, T.9
Levine, H.10
-
139
-
-
34948849855
-
Effectiveness of influenza vaccine in the community-dwelling elderly
-
17914038
-
K.L.Nichol, J.D.Nordin, D.B.Nelson, J.P.Mullooly, E.Hak. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357:1373-81; PMID:17914038; http://dx.doi.org/10.1056/NEJMoa070844
-
(2007)
N Engl J Med
, vol.357
, pp. 1373-1381
-
-
Nichol, K.L.1
Nordin, J.D.2
Nelson, D.B.3
Mullooly, J.P.4
Hak, E.5
-
140
-
-
70149087777
-
The effect of universal influenza immunization on antibiotic prescriptions: an ecological study
-
19624280
-
J.C.Kwong, S.Maaten, R.E.Upshur, D.M.Patrick, F.Marra. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis 2009; 49:750-6; PMID:19624280; http://dx.doi.org/10.1086/605087
-
(2009)
Clin Infect Dis
, vol.49
, pp. 750-756
-
-
Kwong, J.C.1
Maaten, S.2
Upshur, R.E.3
Patrick, D.M.4
Marra, F.5
-
141
-
-
84921731919
-
Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
-
25541296
-
A.Payeras, A.Villoslada, M.Garau, M.N.Salvador, M.C.Gallegos. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine. Int J Infect Dis 2015; 33:22-27; PMID:25541296; http://dx.doi.org/10.1016/j.ijid.2014.12.035
-
(2015)
Int J Infect Dis
, vol.33
, pp. 22-27
-
-
Payeras, A.1
Villoslada, A.2
Garau, M.3
Salvador, M.N.4
Gallegos, M.C.5
-
142
-
-
84954471885
-
Adult vaccination: Now is the time to realize an unfulfilled potential
-
26091249
-
L.Tan. Adult vaccination: Now is the time to realize an unfulfilled potential. Hum Vaccin Immunother 2015; 11:2158-66; PMID:26091249; http://dx.doi.org/10.4161/21645515.2014.982998
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 2158-2166
-
-
Tan, L.1
|